SK283970B6 - Tricyklické zlúčeniny, spôsob výroby a farmaceutický prípravok ich obsahujúci - Google Patents
Tricyklické zlúčeniny, spôsob výroby a farmaceutický prípravok ich obsahujúci Download PDFInfo
- Publication number
- SK283970B6 SK283970B6 SK1150-98A SK115098A SK283970B6 SK 283970 B6 SK283970 B6 SK 283970B6 SK 115098 A SK115098 A SK 115098A SK 283970 B6 SK283970 B6 SK 283970B6
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- alkyl
- carbon atoms
- compound
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5149196 | 1996-03-08 | ||
JP18366796 | 1996-07-12 | ||
JP2918597 | 1997-02-13 | ||
PCT/JP1997/000677 WO1997032871A1 (en) | 1996-03-08 | 1997-03-05 | Tricyclic compounds, their production and use |
Publications (2)
Publication Number | Publication Date |
---|---|
SK115098A3 SK115098A3 (en) | 1999-03-12 |
SK283970B6 true SK283970B6 (sk) | 2004-06-08 |
Family
ID=27286462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1150-98A SK283970B6 (sk) | 1996-03-08 | 1997-03-05 | Tricyklické zlúčeniny, spôsob výroby a farmaceutický prípravok ich obsahujúci |
Country Status (20)
Country | Link |
---|---|
US (1) | US6218429B1 (no) |
EP (2) | EP1550655A1 (no) |
JP (1) | JP4358917B2 (no) |
KR (1) | KR100494214B1 (no) |
CN (3) | CN1900067A (no) |
AT (1) | ATE219071T1 (no) |
CA (1) | CA2241666C (no) |
CZ (1) | CZ291626B6 (no) |
DE (1) | DE69713294T3 (no) |
DK (1) | DK0885210T5 (no) |
ES (1) | ES2175350T5 (no) |
HK (1) | HK1087112A1 (no) |
HU (1) | HU224220B1 (no) |
NO (1) | NO322205B1 (no) |
NZ (1) | NZ330656A (no) |
PL (1) | PL188093B1 (no) |
PT (1) | PT885210E (no) |
SK (1) | SK283970B6 (no) |
TW (1) | TW562803B (no) |
WO (1) | WO1997032871A1 (no) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2773798B1 (fr) | 1998-01-16 | 2001-02-02 | Adir | Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
ATE247967T1 (de) * | 1998-06-09 | 2003-09-15 | Takeda Chemical Industries Ltd | Pharmazeutische kombination mit einem trizyclischen komponent und mindestens einem aus zolpidem, zopiclone und brotizolam, zur behandlung von schlafstörungen |
AU6595000A (en) | 1999-08-20 | 2001-03-19 | Takeda Chemical Industries Ltd. | Dihydrobenzofuran derivatives, process for the preparation thereof and agents |
ATE443526T1 (de) * | 1999-08-20 | 2009-10-15 | Takeda Pharmaceutical | Zusammensetzung für perkutane absorption mit einem melantoninrezeptor-agonistisch wirkendem wirkstoff |
JP4632499B2 (ja) * | 1999-08-26 | 2011-02-16 | 武田薬品工業株式会社 | 鼻粘膜付着マトリックス |
EP1213966B1 (en) * | 1999-09-08 | 2006-04-19 | Bayer CropScience Limited | New herbicidal compositions |
ATE469644T1 (de) * | 2000-11-17 | 2010-06-15 | Takeda Pharmaceutical | Pharmazeutische zubereitung enthaltend n-ä2-(1,6, 7,8-tetrahydro-2h-indenoä5,4 büfuran-8- yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung |
AU2002214306A1 (en) * | 2000-11-17 | 2002-05-27 | Takeda Chemical Industries Ltd. | Pharmaceutical preparation containing talc/barium sulfate |
US6800648B2 (en) * | 2001-04-26 | 2004-10-05 | Wyeth | Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopenta[a]naphthalen-2-one |
IL149377A (en) * | 2002-04-28 | 2012-10-31 | Neurim Pharma 1991 | Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds |
TW200626137A (en) * | 2004-12-13 | 2006-08-01 | Takeda Pharmaceuticals Co | Preventive or therapeutic agent for sleep disorder |
EP1867641A4 (en) * | 2005-04-04 | 2010-01-13 | Takeda Pharmaceutical | A PROPHYLACTIC OR THERAPEUTIC MEDICINE AGAINST AQUEOUS DEPRESSION OR NEUROSIS |
ES2366381T3 (es) * | 2005-06-22 | 2011-10-19 | Takeda Pharmaceutical Company Limited | Comprimido que contiene un ingrediente activo difícilmente soluble. |
US20080280954A1 (en) | 2005-07-29 | 2008-11-13 | Vanda Pharmaceuticals, Inc | Method of Improving Wakefulness |
CA2644181A1 (en) * | 2006-03-20 | 2007-09-27 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for irritable bowel syndrome |
TWI402261B (zh) | 2006-06-19 | 2013-07-21 | Takeda Pharmaceutical | 三環化合物及其醫藥組成物 |
CN101605795A (zh) | 2006-12-08 | 2009-12-16 | 武田药品工业株式会社 | 三环化合物及其药物用途 |
US20080167363A1 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc | Modulation of Neurogenesis By Melatoninergic Agents |
US8247429B2 (en) | 2006-12-28 | 2012-08-21 | Takeda Pharmaceutical Company Limited | Tricyclic compound and pharmaceutical use thereof |
WO2008106179A1 (en) * | 2007-02-26 | 2008-09-04 | Teva Pharmaceutical Industries Ltd. | Intermediates and processes for the synthesis of ramelteon |
JP5289308B2 (ja) | 2007-04-26 | 2013-09-11 | 武田薬品工業株式会社 | 二環性化合物およびその医薬用途 |
EP2069320A2 (en) | 2007-05-31 | 2009-06-17 | Teva Pharmaceutical Industries Ltd. | Process for the synthesis of ramelteon and its intermediates |
US20090105490A1 (en) * | 2007-07-12 | 2009-04-23 | Nurit Perlman | Polymorphic forms of ramelteon and processes for preparation thereof |
ES2324849A1 (es) * | 2007-10-25 | 2009-08-17 | Ferrer Internacional, S.A. | Compuestos de indano. |
US7470814B1 (en) * | 2007-10-31 | 2008-12-30 | Ferrer Internacional, S.A. | Process for the preparation of substituted 7-allyl-6-hydroxy-indanes |
US20090281176A1 (en) * | 2007-11-01 | 2009-11-12 | Vinod Kumar Kansal | Process for the synthesis of ramelteon and its intermediates |
JP5588177B2 (ja) * | 2008-01-31 | 2014-09-10 | 武田薬品工業株式会社 | 注意欠陥・多動性障害の予防または治療剤 |
US8871807B2 (en) | 2008-03-28 | 2014-10-28 | Ecolab Usa Inc. | Detergents capable of cleaning, bleaching, sanitizing and/or disinfecting textiles including sulfoperoxycarboxylic acids |
US8809392B2 (en) | 2008-03-28 | 2014-08-19 | Ecolab Usa Inc. | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
NZ587218A (en) | 2008-03-28 | 2012-04-27 | Ecolab Inc | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
WO2010012789A1 (en) * | 2008-07-30 | 2010-02-04 | Ferrer Internacional S. A. | 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
US20100152468A1 (en) * | 2008-10-16 | 2010-06-17 | Teva Pharmaceutical Industries Ltd. | Process for the synthesis of ramelteon and its intermediates |
AU2009315280A1 (en) * | 2008-11-14 | 2010-05-20 | Watson Pharma Private Limited | Process for the preparation of ramelteon |
US8555875B2 (en) | 2008-12-23 | 2013-10-15 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
US20120071673A1 (en) | 2009-02-12 | 2012-03-22 | Lek Pharmaceuticals D.D. | Synthesis of (s)-n-[2-(1,6,7,8-tetrahydro-2h-indeno-[5,4-b]furan-8-yl)ethyl]propionamide |
WO2010103553A1 (en) * | 2009-03-10 | 2010-09-16 | Industriale Chimica S.R.L. | Process for the preparation of ramelteon |
EP2243775A1 (en) | 2009-04-07 | 2010-10-27 | LEK Pharmaceuticals d.d. | Synthesis of 1-(2,3-Dihydrobenzofuran-4-YL)ethanone as intermediate in the preparation of ramelteon |
CN102648192B (zh) * | 2009-09-29 | 2015-08-26 | 广州南沙龙沙有限公司 | 1,2,6,7-四氢-8h-茚并[5,4-b] 呋喃-8-酮的制备方法 |
WO2012035303A2 (en) | 2010-09-17 | 2012-03-22 | Cipla Limited Et Al | A novel process for synthesis of ramelteon, and key intermediates for the synthesis of ramelteon |
CN102321056B (zh) * | 2011-07-29 | 2014-05-14 | 宁波人健药业集团股份有限公司 | 一种合成雷美替胺的方法 |
CN102391220A (zh) * | 2011-10-10 | 2012-03-28 | 四川大学 | 三环乙醇类化合物及其制备方法和用途 |
US9321664B2 (en) | 2011-12-20 | 2016-04-26 | Ecolab Usa Inc. | Stable percarboxylic acid compositions and uses thereof |
EP2831000A4 (en) | 2012-03-30 | 2016-03-30 | Ecolab Usa Inc | USE OF PERCONDIC ACID / HYDROGEN PEROXIDE AND PEROXIDE REDUCERS FOR THE TREATMENT OF DRILLING LIQUIDS, FRACKING LIQUIDS, REFILL WATER AND DISPOSAL WATER |
US20150368220A1 (en) | 2012-07-10 | 2015-12-24 | Astellas Pharma Inc. | Pharmaceutical composition for treating or preventing stress urinary incontinence or mixed urinary incontinence, and method for screening compound comprised in said pharmaceutical composition |
AR091699A1 (es) | 2012-07-10 | 2015-02-25 | Astellas Pharma Inc | Derivado de indol carboxamida |
CN103724357B (zh) * | 2012-10-11 | 2016-06-08 | 中国药科大学 | 一种3,4-二氢吡喃并[3,2-b]吲哚-2-酮类化合物的合成方法 |
CN102924410A (zh) * | 2012-10-29 | 2013-02-13 | 华润赛科药业有限责任公司 | 一种雷美替胺的制备方法及其中间体 |
US20140256811A1 (en) | 2013-03-05 | 2014-09-11 | Ecolab Usa Inc. | Efficient stabilizer in controlling self accelerated decomposition temperature of peroxycarboxylic acid compositions with mineral acids |
US10165774B2 (en) | 2013-03-05 | 2019-01-01 | Ecolab Usa Inc. | Defoamer useful in a peracid composition with anionic surfactants |
US8822719B1 (en) | 2013-03-05 | 2014-09-02 | Ecolab Usa Inc. | Peroxycarboxylic acid compositions suitable for inline optical or conductivity monitoring |
MX2016009180A (es) | 2014-01-14 | 2016-10-05 | Astellas Pharma Inc | Compuesto de indol. |
AU2017205519B2 (en) | 2016-01-08 | 2022-01-27 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for delirium |
US10759768B2 (en) | 2016-01-08 | 2020-09-01 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for autism spectrum disorder |
CN110776485B (zh) * | 2019-11-22 | 2022-09-30 | 山东邹平大展新材料有限公司 | 一种雷美替胺杂质的制备方法 |
WO2023059546A1 (en) * | 2021-10-04 | 2023-04-13 | Psilosterics, Llc | Serotonin receptor agonists and methods of making and using the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2681862B1 (fr) | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
FR2713636B1 (fr) | 1993-12-07 | 1996-01-05 | Adir | Nouveaux dérivés naphtaléniques, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent. |
GB9326192D0 (en) * | 1993-12-22 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
GB9407919D0 (en) * | 1994-04-21 | 1994-06-15 | Glaxo Group Ltd | Chemical compounds |
FR2725985B1 (fr) † | 1994-10-21 | 1996-11-15 | Adir | Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US5661186A (en) | 1995-02-24 | 1997-08-26 | Bristol-Myers Squibb Co. | Tetralinyl-and indanyl-ethylamides |
-
1997
- 1997-03-05 HU HU9900616A patent/HU224220B1/hu active IP Right Grant
- 1997-03-05 PL PL97328726A patent/PL188093B1/pl unknown
- 1997-03-05 AT AT97905450T patent/ATE219071T1/de active
- 1997-03-05 CA CA002241666A patent/CA2241666C/en not_active Expired - Lifetime
- 1997-03-05 NZ NZ330656A patent/NZ330656A/xx not_active IP Right Cessation
- 1997-03-05 KR KR10-1998-0707080A patent/KR100494214B1/ko not_active IP Right Cessation
- 1997-03-05 DK DK97905450T patent/DK0885210T5/da active
- 1997-03-05 ES ES97905450T patent/ES2175350T5/es not_active Expired - Lifetime
- 1997-03-05 CN CNA200610100063XA patent/CN1900067A/zh active Pending
- 1997-03-05 CN CNB2005100916061A patent/CN100441574C/zh not_active Expired - Lifetime
- 1997-03-05 DE DE69713294T patent/DE69713294T3/de not_active Expired - Lifetime
- 1997-03-05 EP EP04027766A patent/EP1550655A1/en not_active Withdrawn
- 1997-03-05 CZ CZ19982775A patent/CZ291626B6/cs not_active IP Right Cessation
- 1997-03-05 PT PT97905450T patent/PT885210E/pt unknown
- 1997-03-05 SK SK1150-98A patent/SK283970B6/sk not_active IP Right Cessation
- 1997-03-05 CN CNB971927006A patent/CN100443480C/zh not_active Expired - Lifetime
- 1997-03-05 EP EP97905450A patent/EP0885210B2/en not_active Expired - Lifetime
- 1997-03-05 WO PCT/JP1997/000677 patent/WO1997032871A1/en active IP Right Grant
- 1997-03-06 TW TW086102717A patent/TW562803B/zh not_active IP Right Cessation
-
1998
- 1998-08-28 NO NO19983970A patent/NO322205B1/no not_active IP Right Cessation
- 1998-09-22 JP JP26811098A patent/JP4358917B2/ja not_active Expired - Lifetime
-
1999
- 1999-05-10 US US09/309,519 patent/US6218429B1/en not_active Expired - Lifetime
-
2006
- 2006-06-28 HK HK06107304.0A patent/HK1087112A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK283970B6 (sk) | Tricyklické zlúčeniny, spôsob výroby a farmaceutický prípravok ich obsahujúci | |
US6034239A (en) | Tricyclic compounds, their production and use | |
JP2884153B2 (ja) | 三環性化合物、その製造法および剤 | |
EP0781271B1 (en) | Benzocycloalkene compounds, their production and use | |
RU2093513C1 (ru) | Производные 9-деазагуанины или их таутомеры и фармацевтическая композиция, обладающая способностью ингибировать активность пуриннуклеозид фосфорилазы у млекопитающих | |
WO2001014384A1 (fr) | Derives dihydrobenzofuran tricycliques, leur procede de preparation et agents | |
EP1199304A1 (en) | Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders | |
ES2866324T3 (es) | Derivados de 1-(1-hidroxi-2,3-dihidro-1H-inden5-il)-urea y compuestos similares como activadores del canal KCNQ2-5 para el tratamiento de la disuria | |
AU706610C (en) | Tricyclic compounds, their production and use | |
WO2001014385A1 (fr) | Derives de dihydrobenzofuran, leur procede de preparation et agents | |
JP3908798B2 (ja) | ベンゾシクロアルケン類、その製造法および剤 | |
US6071945A (en) | 8H-thieno-[2,3-b]pyrrolizin-8-one compounds | |
JP4721494B2 (ja) | 三環性ジヒドロフラン誘導体、その製造法及び剤 | |
JP4721495B2 (ja) | ジヒドロベンゾフラン誘導体、その製造法及び剤 | |
CA2193398C (en) | Benzocycloalkene compounds, their production and use | |
JPH0517441A (ja) | スピロイソインドリン化合物、その製造方法、それを含有する神経症を治療するための医薬およびそれを製造するための中間体 | |
JPH09118660A (ja) | 芳香族ヒドロキサム酸誘導体、製造法および剤 | |
JPH0995475A (ja) | ベンゾシクロアルケン類、その製造法および剤 | |
JP2006117699A (ja) | ベンゾシクロアルケン類、その製造法および剤 | |
JPH0971568A (ja) | キノリン類、その製造法、中間体および剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Patent expired |
Expiry date: 20170305 |